Zusammenfassung
Infektionen während der Schwangerschaft sind besonders gefürchtet, da nicht nur die Mutter, sondern auch das Kind gefährdet ist.
Literatur
Aboudy Y, Fogel A, Barnea B et al. (1997) Subclinical rubella reinfection during pregnancy followed by transmission of virus to the fetus. J Infect 34: 273–276
Adler SP (1992) Cytomegalovirus and pregnancy. Curr Opin Obstet Gynecol 4: 670–675
Ahlfors K, Ivarsson SA, Bjerre I (1986) Microcephaly and congenital cytomegalovirus infection: a combined prospective and retrospective study of a Swedish infant population. Pediatrics 78: 1058–1063
Akker-van Marle ME, Rijnders ME, Dommelen P (2005) Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease. BJOG 112: 820–826
Alger LS (1997) Toxoplasmosis and parvovirus B19. Infect Dis Clin North Am 11: 55–75
Anderson JE, Koenig LJ, Lampe MA et al. (2005) Achieving universal HIV screening in prenatal care in the United States: provider persistence pays off. AIDS Patient Care STDS 19: 247–252
Andrews EB, Yankaskas BC, Cordero JF et al. (1992) Acyclovir in pregnancy registry: six years´ experience. Obstet Gynecol 79: 711–713
Antiretroviral Pregnancy Registry G (1997) International interim report tor didanosine, indinavir, lamivudine, saquinavir, stavudine, zalcitabine and zidovudine. 1st January 1989–31st December
Apgar BS, Greenberg G, Yen G (2005) Prevention of group B streptococcal disease in the newborn. Am Fam Physician 71: 903–910
Arvin AM, Koropchak CM (1980) Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. J Clin Microbiol 12: 367–374
AWMF (2008) AWMF-Leitlinie 024/020 »GBS in der Schwangerschaft« [www.uni-duesseldorf.de/AWMF/ll/024–020. htm]
AWMF (2008) AWMF-Leitlinie Nr. 059/002 »Diagnostik und Therapie der Syphilies« [www.uni-duesseldorf.de/AWMF/ll/]
Benitz WE, Gould JB, Druzin ML (1999a) Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 103: e78
Benitz WE, Gould JB, Druzin ML (1999b) Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 103: e77
Bergeron MG, Ke D, Menard C et al. (2000) Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 343: 175–179
Best JM, Banatvala JE, Morgan-Capner P et al. (1989) Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ 299: 773–775
Braig S, Luton D, Sibony O et al. (2001) Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol 96: 55–58
Brocklehurst P, French R (1998) The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 105: 836–848
Brown T, Anand A, Richie LD et al. (1984) Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 2
Brown ZA, Selke S, Zeh J et al. (1997) The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337: 509–515
Brown ZA, Wald A, Morrow RA et al. (2003) Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289: 203–209
Buchholz B, Grubert T, Marcus U et al. (2004) German-Austrian recommendations for HIV-therapy in pregnancy: update May 2003. Eur J Med Res 9: 287–303
Burns DN, Mofenson LM (1999) Paediatric HIV11-infection. Lancet 354: SII1–6
Burns DN, Tuomala R, Chang BH et al. (1997) Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during the postpartum period. Women and Infants Transmission Study Group. Clin Infect Dis 24: 201–210
Cacciola I, Pollicino T, Squadrito G et al. (1999) Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341: 22–26
Centers for Disease Control and Prevention (1996) Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 45: 1–24
Centers for Disease Control (2006) Sexually Transmitted Diseases Treatment Guidelines MMWR 55: 1–94
Chapman SJ (1998) Varicella in pregnancy. Semin Perinatol 22: 339–346
Clerici M, Seminari E, Suter F et al. (2000) Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia. The Master Group. Aids 14: 109–116
Connan L, Ayoubi J, Icart J et al. (1996) Intra-uterine fetal death following maternal varicella infection. Eur J Obstet Gynecol Reprod Biol 68: 205–207
Cooper LZ, Green RH, Krugman S et al. (1965) Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero. Am J Dis Child 110: 416–427
Cradock-Watson JE, Miller E, Ridehalgh MK et al. (1989) Detection of rubella virus in fetal and placental tissues and in the throats of neonates after serologically confirmed rubella in pregnancy. Prenat Diagn 9: 91–96
Crum NF, Chun HM, Gaylord TG et al. (2002) Group A streptococcal toxic shock syndrome developing in the third trimester of pregnancy. Infect Dis Obstet Gynecol 10: 209–216
Dabis F, Newell ML, Fransen L et al. (2000) Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV. Health Policy Plan 15: 34–42
Daffos F, Forestier F, Grangeot-Keros L et al. (1984) Prenatal diagnosis of congenital rubella. Lancet 2: 1–3
Daiminger A, Bader U, Enders G (1998) An enzyme linked immunoassay using recombinant antigens for differentiation of primary from secondary or past CMV infections in pregnancy. J Clin Virol 11: 93–102
Deutsch-Österreichische Richtlinien zur postexpositionellen Prophylaxe nach HIV-Exposition (1999) Dtsch Med Wochenschr 123: 111–116
Dieck D, Schild RL, Hansmann M et al. (1999) Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 19: 1119–1123
Djurkovic-Djakovic O (1995) Toxoplasma infection and pathological outcome of pregnancy. Gynecol Obstet Invest 40: 36–41
Duwe S, Brunn M, Altmann D (2001) Frequency of genotypic and phenotypic drug-resistant HIV-l among therapy-naive patients of the German Seroconverter Study. J Acquir Imm Def Syndr 26: 266–273
Eastman PS, Shapiro DE, Coombs RW (1998) Maternal viral genotypic zidovudine resistance and infrequent zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric Clinical Trial Protocol 076. J Infect Dis 177: 557–564
Embleton ND (2001) Fetal and neonatal death from maternally acquired infection. Paediatr Perinat Epidemiol 15: 54–60
Enders G (1984) Varicella-zoster virus infection in pregnancy. Prog Med Virol 29: 166–196
Enders G (1985) Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test. Postgrad Med J 61: 23–30
Enders G (1991) Infektionen und Impfungen in der Schwangerschaft. Urban & amp; Schwarzenberg, Wien Baltimore München
Enders G (1998a) Röteln und Ringelröteln. In Friese K, Kachel W, eds. Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S67–79
Enders G (1998b) Zytomegalie. In: Friese K, Kachel W, eds. Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S90–102
Enders G, Jonatha W (1987) Prenatal diagnosis of intrauterine rubella. Infection 15: 162–164
Enders G, Nickerl U (1988) Rötelnimpfung: Antikörperpersistenz für 1411–7 Jahre und Irnmunstatus von Frauen ohne und mit Impfanamnese. Immun Infekt 16: 58–64
Enders G, Jahn G, Hamprecht K (2006) hCMV-Screening während der Schwangerschaft. Frauenarzt 47: 910–911
Enders G, Nickerl-Pacher U, Miller E et al. (1988) Outcome of confirmed periconceptional maternal rubella. Lancet 1: 1445–1447
Enders G, Miller E, Cradock-Watson J et al. (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343: 1548–1551
Enders G, Bader U, Lindemann L et al. (2001) Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 21: 362–377
European Collaborative Study (1996) Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. European Collaborative Study and Research Network on Congenital Toxoplasmosis. Eur J Obstet Gynecol Reprod Biol 68: 93–96
European Collaborative, Study;Swiss, Mother and Child HIV, Cohort Study (2000) Combination antiretroviral therapy and duration of pregnancy. Aids 14: 2913–2920
European Collaborative Study (2001) HIV-infected pregnant women and vertical transmission in Europe since 1986. Aids 15: 761–770
European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40: 458–465
European Group C (1996) Children born to women with HIV11-infection: natural history and risk of vertical transmission. Lancet (1991) 337: 253–260
Feinberg MB (1996) Changing the natural history of HIV disease. Lancet 348: 239–246
Frenkel LM, Cowles MK, Shapiro DE et al. (1997) Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis 175: 971–974
Friese K (1998) Herpes genitalis. In: Friese K, Kachel W Infektionserkrankungen eds. der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S108–117
Friese K (2000) Hepatitis A und B Immunization. Gynäkologe 33: 574–582
Friese K (2002) Infection screening in pregnancy. Gynakologe 35: 669–673
Friese K, Enders G (1998) Varizellen-Zoster. In: Friese K, Kachel W, Infektionserkrankungen eds. der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S102–108
Friese K, Hlobil H (1997) Prenatal toxoplasmosis–do we need screening in pregnancy? Z Geburtshilfe Neonatol 201: 115–120
Friese K, Beichert M, Hof H et al. (1991a) Incidence of congenital infections. Geburtshilfe Frauenheilkd 51: 890–896
Friese K, Beichert M, Hof H et al. (1991b) Studies on the Incidence Rate of Connatal Infections. Geburtshilfe Frauenheilkd 51: 890–896
Friese K, Schäfer A, Hof H (2002) Infektionskrankheiten in Gynäkologie und Geburtshilfe. Springer, Berlin Heidelberg New York
Garcia PM, Kalish LA, Pitt J et al. (1999) Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341: 394–402
Giles M, Hellard M, Sasadeusz J (2003) Hepatitis C and pregnancy: an update. Aust N Z J Obstet Gynaecol 43: 290–293
Gilstrap LC, Faro S (1997) Infections in pregnancy., 2nd edn. Wiley-Liss, New York Chichester Weinheim Brisbane Singapore Toronto
Gingelmaier A, Friese K (2005) Betreuung HIV-positiver Frauen in der Schwangerschaft und unter der Geburt. Gynäkologe 38: 688–693
Goncalves LF, Chaiworapongsa T, Romero R (2002) Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 8: 3–13
Graves N, Walker DG, McDonald AM et al. (2004) Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia. J Infect Dis 190: 166–174
Grillner L, Forsgren M, Barr B et al. (1983) Outcome of rubella during pregnancy with special reference to the 17th–24th weeks of gestation. Scand J Infect Dis 15: 321–325
Grosch-Worner I, Schafer A, Obladen M et al. (2000) An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV11- infection. Aids 14: 2903–2911
Haddow LJ, Mindel A (2006) Genital herpes vaccines – cause for cautious optimism. Sex Health 3 (1): 1–4
Hansmann M, Gembruch U, Bald R (1989) New therapeutic aspects in nonimmune hydrops fetalis based on four hundred and two prenatally diagnosed cases. Fetal Ther 4: 29–36
Hartung J, Enders G, Chaoui R et al. (1999) Prenatal diagnosis of congenital varicella syndrome and detection of varicella-zoster virus in the fetus: a case report. Prenat Diagn 19: 163–166
Hedrick J (1996) The effects of human parvovirus B19 and cytomegalovirus during pregnancy. J Perinat Neonatal Nurs 10: 30–39
Henrich W, Meckies J, Dudenhausen JW et al. (2002) Recurrent cytomegalovirus infection during pregnancy: ultrasonographic diagnosis and fetal outcome. Ultrasound Obstet Gynecol 19: 608–611
Hercogova J, Brzonova I (2001) Lyme disease in central Europe. Curr Opin Infect Dis 14: 133–137
Higa K, Dan K, Manabe H (1987) Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol 69: 214–222
Hitti J, Watts H (2008) Bacterial sexually transmitted infections in pregnancy. In: Holmes KK, Parling PF, Stamm WE et al. (eds) Sexually transmitted diseases, 4th edn. McGraw Hill, New York, pp 1529–1561
Hohlfeld P, Daffos F, Costa JM et al. (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amnioticfluid. N Engl J Med 331: 695–699
Hollm-Delgado MG, Allard R, Pilon PA (2005) Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995–2001. Emerg Infect Dis 11
Hollwitz B, Gingelmaier A, Gröger S (2004) Course of pregnancy and fetal outcome of 597 HIV-exposed pregnancies in german reference centers 1999–2003. World AIDS Conference Poster ThPeB7119
Hoyme, U. B. (2007) Urogenitalinfektionen mit Chlamydia trachomatis. Frauenarzt 48: 339–345
International Perinatal HIV Group (2001) Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. Aids 15: 357–368
Ioannidis JP, Abrams EJ, Ammann A et al. (2004) Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads & lt;1000 copies/ml. J Infect Dis (2001) 183: 539–545
Johnson G, Nelson S, Petric M et al. (2000) Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol 38: 3274–3279
Jordan JA (1996) Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 174: 37–42
Keutel J (1968) Angeborene Varizellen. Z. Kinderheilkd 102: 266–272
Kind C, Rudin C, Siegrist CA et al. (1998) Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. Aids 12: 205–210
Komischke K, Searle K, Enders G (1997) Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications. Prenat Diagn 17: 1039–1046
Krause PR, Straus SE (1999) Herpesvirus vaccines. Development, controversies, and applications. Infect Dis Clin North Am 13: 61–81
Kulhanjian JA, Soroush V, Au DS et al. (1992) Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 326: 916–920
Lancefield RC, Hare R (1935) Serologic differentiation of pathogenic and nonpathogenic strain of hemolytic streptococci from parturient women. J Exp Med 61: 335–349
Lee SI, Lo KJ, Tsai YT et al. (1988) Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 11: 833–834
Leikin E, Lysikiewicz A, Garry D et al. (1996) Intrauterine transmission of hepatitis A virus. Obstet Gynecol 88: 690–691
Leroy V, Newell ML, Dabis F et al. (1998) International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV11-infection. Ghent International Working Group on Motherto-Child Transmission of HIV. Lancet 352: 597–600
Maine GT, Lazzarotto T, Landini MP (2001) New developments in the diagnosis of maternal and congenital CMV infection. Expert Rev Mol Diagn 1: 19–29
Mandelbrot L (1998) Vertical transmission of viral infections. Curr Opin Obstet Gynecol 10: 123–128
Marcus U (1999) AIDS und HIV-Infektionen bei Frauen und Kindern in Deutschland. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 42: 553–557
Mayaud P (1997) Tackling bacterial vaginosis and HIV in developing countries. Lancet 350: 530–531
Miller E, Cradock-Watson JE, Pollock TM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2: 781–784
Miller E, Cradock-Watson JE, Ridehalgh MKS (1989) Outcome in newborn babies given antivaricella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 2: 371–373
Miller E, Fairley CK, Cohen BJ et al. (1998) Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105: 17411–17478
Minkoff HL (1998) Human immunodeficiency virus infection in pregnancy. Semin Perinatol 22: 293–308
Mofenson LM, Harris DR, Rich K et al. (1999a) Serum HIV11-p24 antibody, HIV11-RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV11-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Aids 13: 31–39
Mofenson LM, Lambert JS, Stiehm ER et al. (1999b) Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 341: 385–393
Mofenson LM (2005) Efavirenz reclassified as FDA pregnancy category D. AIDS Clin Care 17 (2): 17
Moodley J, Moodley D, Pillay K et al. (1998) Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis 178: 1327–1333
Morgan-Capner P, Miller E, Vurdien JE et al. (1991) Outcome of pregnancy after maternal reinfection with rubella. CDR (Lond Engl Rev) 1: R57–59
Müller F (1996) Treponematosen. In: Thomas LH Labor und Diagnose. Medizinische Verlagsgesellschaft, Marburg, S 1530–
Mylonas I, Friese K (2004a) Infektionsbedingte fetale Schädigungen. In Ganten D, Ruckpaul W, eds. Grundlagen der Molekularmedizin – Fetale und Neonatale Schädigungen. Springer, Berlin Heidelberg New York
Mylonas I, Friese K (2004b) Lyme-Borreliose in der Schwangerschaft: Wie gross ist das Risiko einer fetalen Schädigung? Frauenarzt 45: 529–535
Mylonas I, Friese K (2005) Fetal cytomegalovirus infection: From research to clinical application. Geburtshilfe Frauenheilkd 65: 465–473
Mylonas I, Friese K (2009) Infektionen in Gynäkologie und Geburtshilfe. Elsevier, Amsterdam
Mylonas I, Bauerfeind I, Friese K (2005a) Impfungen in der Schwangerschaft. Gynäkologe 38: 771–779
Mylonas I, Enders G, Tewald F et al. (2005b) Lyme-Borreliose in Schwangerschaft, Wochenbett und Stillzeit. Frauenarzt 46: 108–113
Mylonas I, Gingelmaier A, Friese K (2006a) Systemische Infektionen in der Geburtshilfe. Gynäkologe 39: 223–232
Mylonas I, Gutsche S, Anton G et al. (2006b) Parvovirus-B19-Infektionen in der Schwangerschaft. Zentralbl Gynäkol 39 (3): 223–232
Mylonas I, Kirschner W, Weissenbacher T et al. (2007) Chlamydia trachomatis – Zeit zum Handeln? Dtsch Med Wochenschr 25; 132 (21): 1170–1176
Nakashima K, lkematsu H, Hayashi J et al. (1995) Intrafamilial Transmission of Hepatitis C Virus Among the Population of an Endemic Area of Japan. JAMA 274: 1459–1461
Nigro G, La Torre R, Mazzocco M et al. (1999) Multi-system cytomegalovirus fetopathy by recurrent infection in a pregnant woman with hepatitis B. Prenat Diagn 19: 1070–1072
Nigro G, Adler SP, La Torre R, Best AM, Group CCC (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353: 1402–1404
Ohto H, Terazawa S, Sasaki N (1994) Transmission of hepatitis C virus from mothers to infants. The vertical transmission of hepatitis C virus collaborative study group. N Engl J Med 330: 744–750
Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 19; 360 (12): 1191–1199
Paryani SG, Arvin AM (1986) Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 314: 1542–1546
Pastuszak AL, Levy M, Schick B et al. (1994) Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330: 901–905
Petersen EE (1997) Infektionen während der Schwangerschaft und Geburt. Thieme, Stuttgart New York
Peyron F, Wallon M, Liou C, Garner P. (2000) Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev (2): CD001684
Pieringer-Müller E, Hof H (1998) Syphilis. In: Friese K, Kachel W eds. Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S235–256
Pillay T, Phillips RE (2005) Adaptive evolution in perinatal HIV11-. Best Pract Res Clin Obstet Gynaecol 19: 211–229
Plunkett BA, Grobman WA (2005) Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis. Am J Obstet Gynecol 192: 1153–1161
Poulton J, Lyall H, Taylor G et al. (1999) HIV11- therapy and fetal mitochondrial dysfunction. Lancet 354: 2081–2082
Prober CG, Gershon AA, Grose C et al. (1990) Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J 9: 865–869
Prober CG, Corey L, Brown ZA et al. (1992) The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 15: 1031–1038
Public Health Service Task Force (2004) Recommendations for use of antiretroviral drugs in pregnant HIV-1–infected women for maternal health and interventions to reduce perinatal HIV-1-transmission in the United States. [www.hivatis.org]
Randolph AG, Washington AE, Prober CG (1993) Cesarean delivery for women presenting with genital herpes lesions. Effcacy, risks, and costs. Jama 270: 77–82
Ranger-Rogez S, Denis F (2004) Hepatitis B mother–to–child transmission. Expert Rev Anti Infect Ther 2: 133–145
Rawstron SA, Vetrano J, Tannis G et al. (1997) Congenital syphilis: detection of Treponema pallidum in stillborns. Clin Infect Dis 24: 24–27
Read JS (2000) Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations. Ann NY Acad Sci 918: 115–121
Reinus JF, Leikin EL, Alter HJ et al. (1992) Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 117: 881–886
Resti M, Azzari C, Galli L et al. (2002) Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 185: 567–572
Revello MG, Gerna G (2004) Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol 29: 71–83
Rokos K, Wang H, Seeger J et al. (1998) Transport of viruses through fetal membranes: an in vitro model of perinatal transmission. J Med Virol 54: 313–319
Roos R, Proquitte H (1998) Infektionen des Neu- und Frühgeborenen durch Streptokokken der GruppeB. In Friese K, Kachel W, eds. Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S210–218
Rossol S (1998) Hepatitisinfektion der Schwangeren. In: Friese K, Kachel W, eds. Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S118–135
Rouse DJ, Goldenberg RL, Cliver SP et al. (1994) Strategies for the prevention of early onset neonatal group B streptococcal sepsis: A decision analysis. Obstet Gynecol 83: 483–494
Rudin C, Boubaker K, Raeber PA et al.; and the Hohlfeld Swiss Working Group on congenital Toxoplasmosis (2008) Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland. Swiss Med Weekly 138 (Suppl 168): 1–8
Sauerbrei A, Wutzler P (2000) The congenital varicella syndrome. J Perinatol 20: 548–554
Sauerbrei A, Wutzler P (2001) Neonatal varicella. J Perinatol 21: 545–549
Sauerbrei A, Wutzler P (2007a) Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: Herpes simplex virus infections. Med Microbiol Immunol 196 (2): 89–94
Sauerbrei A, Wutzler P (2007b) Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol 196 (2): 95–102
Sauerbrei A, Sonntag S, Wutzler P (1990) Durchseuchung von Schwangeren mit dem Varizella-Zoster-Virus. Zentralbl Gynäkol 112: 223–226
Schleiss MR (2003) Vertically transmitted herpesvirus infections. Herpes 10: 4–11
Schneider T, Wirth S (1998) Hepatitisinfektion des Neugeborenen. In: Friese K, Kachel W Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York, S136–150
Schwarz TF, Roggendorf M, Hottentrager B et al. (1988) Human parvo-virus B19 infection in pregnancy. Lancet 2: 566–567
Schwebke K, Henry K, Balfour HH Jr. et al. (1995) Congenital cytomegalovirus infection as a result of nonprimary cytomegalovirus disease in a mother with acquired immunodeficiency syndrome. J Pediatr 126: 293–295
Scott LL, Hollier LM, McIntire D et al. (2001) Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial. Infect Dis Obstet Gynecol 9: 75–80
Scott LL, Hollier LM, McIntire D et al. (2002) Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 10: 71–77
Selbing A, Josefsson A, Dahle LO et al. (1995) Parvovirus B19 infection during pregnancy treated with high-dose intravenous gamma-globulin. Lancet 345: 660–-661
Shaffer N (2001) Combination prophylaxis for prevention of maternal-infant HIV transmission: beyond 076. JAMA 285: 2129–2131
Shapiro DE, Sperling RS, Mandelbrot L et al. (1999) Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol 94: 897–908
Shapiro G (1994) Transmission of hepatitis B virus between institutionalized children. Pediatr Infect Dis J) 13: 245–246
Shearer WT, Quinn TC, LaRussa P et al. (1997) Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 336: 1337–1342
Sherlock S (1996) The liver in pregnancy. In: Sherlock S Diseases of the liver and biliary system. Blackwell, Oxforfd
Siegl G (2004) Hepatitis A and E enterically transmitted virus infections of the liver. Ther Umschau 61: 481–486
Singh AE, Romanowski B (1999) Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 12: 187–209
Singh SK, Girschick HJ (2004) Lyme borreliosis: from infection to autoimmunity. Clinical Microbiology and Infection 10: 598–614
Sperling RS, Shapiro DE, McSherry GD et al. (1998) Safety of the ma-ternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. Aids 12: 1805–1813
Stagno S (1990) Significance of cytomegaloviral infections in pregnancy and early childhood. Pediatr Infect Dis J 9: 763–764
Stagno S, Whitley RJ (1985) Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med 313: 1327–1330
Stanberry LR, Cunningham AL, Mindel A et al. (2000) Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 30: 549–566
Steere AC, Bartenhagen NH, Craft JE et al. (1986) Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A 263: 201–205
Stray-Pedersen B (1990) Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet 336: 756
Stray-Pedersen B (1993) New aspects of perinatal infections. Ann Med 25: 295–300
Stray-Pedersen B, Jenum P (1992) Current status of toxoplasmosis in pregnancy in Norway. Scand J Infect Dis Suppl 84: 80–83
Strobino BA, Williams CL, Abid S et al. (1993) Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol 169: 367–374
Strobino B, Abid S, Gewitz M (1999) Maternal Lyme disease and congenital heart disease: A case-control study in an endemic area. Am J Obstet Gynecol 180: 711–716
The International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 – a meta-analysis of 15 prospective cohort studies. N Engl J Med 340: 977–987
Thiébaut R, Leproust S, Chêne G, Gilbert R; and SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 13; 369 (9556): 115–122
Van Elsacker-Niele AM, Salimans, Weiland HT et al. (1989) Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 96: 768–775
Vocks-Hauck M (2001) HIV-Infektion und AIDS bei Neugeborenen, Kindern und Jugendlichen. Springer, Berlin Heidelberg New York
Von Krosigk A, Jäger H (2005) Aspekte der HIV-Therapie in der Schwangerschaft. Gynäkologe 38: 694–700
Walker DG, Walker GJ (2002) Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infect Dis 2: 432–436
Warszawski J, Tubiana R, Le Chenadec J et al. (2008) Mother to child HIV transmission despite antiretroviral therapy in the ARNS French Perinatal Cohort: AIDS 22: 289–299
Watson JC, Fleming DW, Borella AI et al. (1993) Vertikal transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis 167: 567–571
Wattre P, Dewilde A, Subtil D et al. (1998) A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection. J Med Virol 54: 14011–44
Weber K, Bratzke HJ, Neubert U et al. (1988) Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 7: 286–289
Welles SL, Pitt J, Colgrove R et al. (2000) HIV11-genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the Women and Infants Transmission Study. AIDS 14: 263–271
Whitley RJ (1996) Herpes simplex viruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Virology. Raven, New York, pp 2297–2342
Wilske B, Zöller L, Brade V et al. (2000) Lyme-Borreliose. MiQ: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik 12: 1–60
Wutzler P, Farber I, Wagenpfeil S et al. (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20: 121–124
Yaegashi N, Niinuma T, Chisaka H et al. following maternal infection. Report of 10 cases and meta-analysis. J Infect (The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis 1998) 37: 28–35
Young EJ, Chafizadeh E, Oliveira VL et al. (1996) Disseminated herpesvirus infection during pregnancy. Clin Infect Dis 22: 51–58
Zieger W, Friese K, Weigel M et al. (1994) Varizellen-Infektion am Geburtstermin. Z Geburtsh Perinatol 198: 134–137
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) [www.dggg.de]
Arbeitsgemeischaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF) [www.awmf-online.de]
Robert Koch-Institut [www.rki.de]
Deutsches Grünes Kreuz für Gesundheit e. V. [www.dgk.de]
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mylonas, I., Friese, K. (2011). Infektionen in der Geburtshilfe. In: Schneider, H., Husslein, PW., Schneider, K. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12974-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-12974-2_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40181-7
Online ISBN: 978-3-642-12974-2
eBook Packages: Medicine (German Language)